Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil

Perazzo, H, Jorge, MJ, Silva, JC et al. (8 more authors) (2017) Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil. BMC Gastroenterology, 17 (1). 119. ISSN 1471-230X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s). 2017. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Chronic hepatitis C; Treatment; Micro-costing
Dates:
  • Published: 23 November 2017
  • Accepted: 15 November 2017
  • Published (online): 23 November 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 12 Feb 2020 10:47
Last Modified: 12 Feb 2020 10:47
Status: Published
Publisher: BMC
Identification Number: https://doi.org/10.1186/s12876-017-0676-8

Share / Export

Statistics